NTRK2 and Alzheimer disease: We will provide an overview of the BDNF/TrkB signalling pathway and its dysregulation in AD, followed by the key preclinical and clinical findings of stem cell therapy and the evidence of its mechanistic action via the BDNF/TrkB signalling pathway.